•• Graus F, Vogrig A, Muñiz-Castrillo S, Antoine JCG, Desestret V, Dubey D, et al. Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm 2021;8:e1014. https://doi.org/10.1212/NXI.0000000000001014. An important consensus document on the updated diagnostic classification and terminology of paraneoplastic neurologic disorders.

Graus F, Keime-Guibert F, Reñe R, Benyahia B, Ribalta T, Ascaso C, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124:1138–48. https://doi.org/10.1093/brain/124.6.1138.

Article  CAS  PubMed  Google Scholar 

Lai M, Hughes EG, Peng X, Zhou L, Gleichman AJ, Shu H, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol. 2009;65:424–34. https://doi.org/10.1002/ana.21589.

Article  CAS  PubMed  PubMed Central  Google Scholar 

• Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ, et al. Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis. JAMA Neurol. 2016;73:1297–307. https://doi.org/10.1001/jamaneurol.2016.2549. Although more often an idiopathic autoimmune disorder, GFAP astrocytopathy can occur as a paraneoplastic disorder in approximately one third of cases.

Article  PubMed  Google Scholar 

•• Vogrig A, Gigli GL, Segatti S, Corazza E, Marini A, Bernardini A, et al. Epidemiology of paraneoplastic neurological syndromes: a population-based study. J Neurol. 2020;267:26–35. https://doi.org/10.1007/s00415-019-09544-1. The first epidemiological study of paraneoplastic neurologic disorders which highlighted a much higher prevalence of these disorders than previously reported.

Article  CAS  PubMed  Google Scholar 

Dalmau J, Geis C, Graus F. Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev. 2017;97:839–87. https://doi.org/10.1152/physrev.00010.2016.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bien CG, Vincent A, Barnett MH, Becker AJ, Blümcke I, Graus F, et al. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain. 2012;135:1622–38. https://doi.org/10.1093/brain/aws082.

Article  PubMed  Google Scholar 

Corsellis JA, Goldberg GJ, Norton AR. “Limbic encephalitis” and its association with carcinoma. Brain. 1968;91:481–96. https://doi.org/10.1093/brain/91.3.481.

Article  CAS  PubMed  Google Scholar 

Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003;349:1543–54. https://doi.org/10.1056/NEJMra023009.

Article  CAS  PubMed  Google Scholar 

Gozzard P, Woodhall M, Chapman C, Nibber A, Waters P, Vincent A, et al. Paraneoplastic neurologic disorders in small cell lung carcinoma. Neurol. 2015;85:235–9. https://doi.org/10.1212/WNL.0000000000001721.

Article  Google Scholar 

• Shah S, Flanagan EP, Paul P, Smith CY, Bryant SC, Devine MF, et al. Population-based epidemiology study of paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm 2022;9:e1124. https://doi.org/10.1212/NXI.0000000000001124. Prevalence and incidence of paraneoplastic neurologic disorders in Olmsted county, Minnesota.

Hébert J, Riche B, Vogrig A, Muñiz-Castrillo S, Joubert B, Picard G, et al. Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France. Neurol Neuroimmunol Neuroinflamm 2020;7:e883. https://doi.org/10.1212/NXI.0000000000000883.

Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, et al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol. 2018;83:166–77. https://doi.org/10.1002/ana.25131.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dubey D, David WS, Reynolds KL, Chute DF, Clement NF, Cohen JV, et al. Severe neurological toxicity of immune checkpoint inhibitors: growing spectrum. Ann Neurol. 2020;87:659–69. https://doi.org/10.1002/ana.25708.

Article  PubMed  Google Scholar 

Sechi E, Markovic SN, McKeon A, Dubey D, Liewluck T, Lennon VA, et al. Neurologic autoimmunity and immune checkpoint inhibitors: autoantibody profiles and outcomes. Neurol. 2020;95:e2442–52. https://doi.org/10.1212/WNL.0000000000010632.

Article  CAS  Google Scholar 

McKeon A, Pittock SJ. Paraneoplastic encephalomyelopathies: pathology and mechanisms. Acta Neuropathol. 2011;122:381–400. https://doi.org/10.1007/s00401-011-0876-1.

Article  CAS  PubMed  Google Scholar 

Moscato EH, Peng X, Jain A, Parsons TD, Dalmau J, Balice-Gordon RJ. Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol. 2014;76:108–19. https://doi.org/10.1002/ana.24195.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J, et al. Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 2010;9:67–76. https://doi.org/10.1016/S1474-4422(09)70324-2.

Article  CAS  PubMed  Google Scholar 

Kornau HC, Kreye J, Stumpf A, Fukata Y, Parthier D, Sammons RP, et al. Human Cerebrospinal fluid monoclonal LGI1 autoantibodies increase neuronal excitability. Ann Neurol. 2020;87:405–18. https://doi.org/10.1002/ana.25666.

Article  CAS  PubMed  Google Scholar 

Debanne D, el Far O. Pre- and postsynaptic effects of LGI1 autoantibodies in a murine model of limbic encephalitis. Brain. 2018;141:3084–97. https://doi.org/10.1093/brain/awy271.

Article  Google Scholar 

Hinson SR, Romero MF, Popescu BFGh, Lucchinetti CF, Fryer JP, Wolburg H, et al. Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc Natl Acad Sci. 2012;109:1245–50. https://doi.org/10.1073/pnas.1109980108.

Article  PubMed  Google Scholar 

McKeon A, Pittock SJ, Glass GA, Josephs KA, Bower JH, Lennon VA, et al. Whole-body tremulousness. Arch Neurol. 2007;64:1318. https://doi.org/10.1001/archneur.64.9.1318.

Article  PubMed  Google Scholar 

O’Toole O, Lennon VA, Ahlskog JE, Matsumoto JY, Pittock SJ, Bower J, et al. Autoimmune chorea in adults. Neurol. 2013;80:1133–44. https://doi.org/10.1212/WNL.0b013e3182886991.

Article  CAS  Google Scholar 

Shams’Ili S, Grefkens J, de Leeuw B, van den Bent M, Hooijkaas H, van der Holt B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain. 2003;126:1409–18. https://doi.org/10.1093/brain/awg133.

Article  PubMed  Google Scholar 

McKeon A, Tracy JA, Pittock SJ, Parisi JE, Klein CJ, Lennon VA. Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond. Arch Neurol. 2011;68:1280–7. https://doi.org/10.1001/archneurol.2011.128.

Article  Google Scholar 

Dubey D, Wilson MR, Clarkson B, Giannini C, Gandhi M, Cheville J, et al. Expanded clinical phenotype, oncological associations, and immunopathologic insights of paraneoplastic Kelch-like protein-11 encephalitis. JAMA Neurol. 2020;77:1420–9. https://doi.org/10.1001/jamaneurol.2020.2231.

Article  PubMed  Google Scholar 

• Mandel-Brehm C, Dubey D, Kryzer TJ, O’Donovan BD, Tran B, Vazquez SE, et al. Kelch-like protein 11 antibodies in seminoma-associated paraneoplastic encephalitis. N Engl J Med. 2019;381:47–54. https://doi.org/10.1056/nejmoa1816721. (A novel paraneoplastic rhombencephalitis which predominantly affects men with testicular cancer.)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pittock SJ, Lucchinetti CF, Lennon VA. Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol. 2003;53:580–7. https://doi.org/10.1002/ana.10518.

Article  CAS  PubMed  Google Scholar 

Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391–404. https://doi.org/10.1016/S1474-4422(15)00401-9.

Article  PubMed  PubMed Central  Google Scholar 

Lawn ND, Westmoreland BF, Kiely MJ, Lennon VA, Vernino S. Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc. 2003;78:1363–8. https://doi.org/10.4065/78.11.1363.

Article  PubMed  Google Scholar 

Quek AML, Britton JW, McKeon A, So E, Lennon VA, Shin C, et al. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol. 2012;69:582–93. https://doi.org/10.1001/archneurol.2011.2985.

Article  PubMed  PubMed Central  Google Scholar 

Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12:157–65. https://doi.org/10.1016/S1474-4422(12)70310-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dalmau J, Armangué T, Planagumà J, Radosevic M, Mannara F, Leypoldt F, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;18:1045–57. https://doi.org/10.1016/S1474-4422(19)30244-3.

Article  CAS  PubMed  Google Scholar 

Spatola M, Petit-Pedrol M, Simabukuro MM, Armangue T, Castro FJ, Barcelo Artigues MI, et al. Investigations in GABA A receptor antibody-associated encephalitis. Neurol. 2017;88:1012–20. https://doi.org/10.1212/WNL.0000000000003713.

Article  CAS  Google Scholar 

Pettingill P, Kramer HB, Coebergh JA, Pettingill R, Maxwell S, Nibber A, et al. Antibodies to GABAA receptor 1 and 2 subunits: clinical and serologic characterization. Neurol. 2015;84:1233–41. https://doi.org/10.1212/WNL.0000000000001326.

Article  CAS  Google Scholar 

Boronat A, Gelfand JM, Gresa-Arribas N, Jeong HY, Walsh M, Roberts K, et al. Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol. 2013;73:120–8. https://doi.org/10.1002/ana.23756.

Article  CAS  PubMed  Google Scholar 

Tobin WO, Lennon VA, Komorowski L, Probst C, Clardy SL, Aksamit AJ, et al. DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients. Neurol. 2014;83:1797–803. https://doi.org/10.1212/WNL.0000000000000991.

Article  CAS  Google Scholar 

Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, et al. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients. Ann Neurol. 2017;81:298–309. https://doi.org/10.1002/ana.24881.

Article  CAS  PubMed